The legislative panel responsible for approving the rules that will govern South Dakota’s new medical marijuana law has approved a number of proposed regulations and sent other proposals back for review, in what was a crucial administrative step toward implementing the new statewide program.

Wesana looks to expand its TBI-based psychedelics research into MDMA, with a new research partnership with MAPS.

Detroit could become one of the next Michigan cities to decriminalize psychedelics, with the reform proposal making the local ballot for this November.

Cannabis flower is now available to Virginia patients who can purchase up to four ounces per month, WRIC reports.

Big Pharma’s business model for drug development is all about maximizing profits, not health. Psychedelic medicine can maximize profits AND health.

Psyched Wellness moves a step closer to commencing its Phase I clinical trial on AME-1. The company is still targeting commercialization for 2022.

Psychedelics media star, Hamilton Morris is joining Compass Pathways as a full-time consultant on psychedelics research.

Youth marijuana use does not increase after states enact legalization for medical or recreational use, researchers concluded in a study published in a prominent scientific journal on Tuesday.

Two BILLION people with untreated mental health disorders is a lot of market potential. We attach some numbers to these treatment markets.

Field Trip will focus on Treatment-Resistant Depression and Postpartum Depression as indications for drug development of FT-104.